Timothy Henkel

Venatorx Pharmaceuticals, Inc.

$48,583,055

Attributed

$48,583,055

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $12.3M · FY2016–24

$20M$15M$10M$5M$0

'16

'17

'18

'19

'20

'21

'22

'23

'24

Funding mix

By agency

NIH$48,583,055 · 1

By mechanism

N01$48,583,055 · 1

Top collaborators

No co-investigators on record.

Most similar at Venatorx Pharmaceuticals, Inc.

Same institution · by research overlap

Luigi Xerri$39,662,982
Denis Marc Daigle$7,512,530
Daniel Pevear$25,064,821
Steven Armen Boyd$13,685,544
Bin Liu$3,147,000

Others in their field

Top investigators on “Therapeutic Development”

Sonia M Thomas · Research Triangle Institute$700,865,642
David Heimbrook · Leidos Biomedical Research, Inc.$547,603,444
Bambra Strokes · Ppd Development Lp$526,656,217
Tracy L Nolen · Research Triangle Institute$474,487,152
Judith S. Currier · University Of California Los Angeles$326,346,444
Leonard Freedman · Leidos Biomedical Research, Inc.$311,659,176

Research focus

Therapeutic DevelopmentBacterial Drug ResistanceEmerging Communicable DiseasesAdvanced DevelopmentGram-Negative BacteriaBiodefenseBacterial InfectionsBacterial ResistanceProduct DevelopmentClinical ResearchEfficacy EvaluationResearch And DevelopmentTherapeutic CandidatePre-ClinicalChemistryManufactureSafety AssessmentResistanceAntibiotic ResistanceAntimicrobial ResistanceAntimicrobial Resistant PathogenCandidate SelectionCategoriesClinical Assessments